About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Il6tm1Kopf
targeted mutation 1, Manfred Kopf
MGI:1857197
Summary 25 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Il6tm1Kopf/Il6tm1Kopf B6.129S2-Il6tm1Kopf/J MGI:3629043
hm2
Il6tm1Kopf/Il6tm1Kopf involves: 129S2/SvPas MGI:3837132
hm3
Il6tm1Kopf/Il6tm1Kopf involves: 129S2/SvPas * C57BL/6 MGI:2180049
hm4
Il6tm1Kopf/Il6tm1Kopf involves: 129S2/SvPas * C57BL/6J * CE/J MGI:4453191
cn5
Il6tm1Kopf/Il6tm1Kopf
Junbtm3Wag/Junbtm3Wag
Tg(KRT5-cre)1Tak/0
involves: 129/Sv * 129P2/OlaHsd * 129S2/SvPas * C3H * C57BL/6 MGI:4417905
cn6
Il6tm1Kopf/Il6+
Prdm1tm1Clme/Prdm1tm1Clme
Tg(Itgax-cre)1-1Reiz/0
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * CBA MGI:5515639
cx7
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu
Il6tm1Kopf/Il6tm1Kopf
B6.Cg-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu Il6tm1Kopf MGI:5563040
cx8
Il6tm1Kopf/Il6tm1Kopf
Tg(ED-L2-IL1RN/IL1B)#Tcw/?
B6.Cg-Il6tm1Kopf Tg(ED-L2-IL1RN/IL1B)#Tcw MGI:5308014
cx9
Il6tm1Kopf/Il6+
Tg(ED-L2-IL1RN/IL1B)#Tcw/?
B6.Cg-Il6tm1Kopf Tg(ED-L2-IL1RN/IL1B)#Tcw MGI:5308015
cx10
Il6tm1Kopf/Il6tm1Kopf
Inpp5dtm1Rkh/Inpp5dtm1Rkh
involves: 129 * C57BL/6 MGI:3838993
cx11
Il6tm1Kopf/Il6tm1Kopf
Tanktm1Aki/Tanktm1Aki
involves: 129/Sv * 129S2/SvPas * C57BL/6 MGI:4355832
cx12
Il11ra1tm1Wehi/Il11ra1tm1Wehi
Il6tm1Kopf/Il6tm1Kopf
involves: 129/Sv * C57BL/6 MGI:3604406
cx13
Il6tm1Kopf/Il6tm1Kopf
Il6sttm1Ern/Il6sttm1Ern
involves: 129S1/Sv * 129S2/SvPas MGI:3837308
cx14
Il6tm1Kopf/Il6tm1Kopf
Liftm1Stw/Liftm1Stw
involves: 129S1/Sv * 129S2/SvPas * C57BL/6 MGI:4834760
cx15
Ctsctm1Ley/Ctsctm1Ley
Il6tm1Kopf/Il6tm1Kopf
involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 MGI:3696456
cx16
Il6tm1Kopf/Il6tm1Kopf
Npc1m1N/Npc1m1N
involves: 129S2/SvPas * BALB/c * C57BL/6 MGI:3706955
cx17
Il6tm1Kopf/Il6+
Ncoa5tm1Hxia/Ncoa5+
involves: 129S2/SvPas * BALB/c * C57BL/6 MGI:5581716
cx18
Il6tm1Kopf/Il6tm1Kopf
Tg(Rorc-EGFP)1Ebe/?
involves: 129S2/SvPas * C57BL/6 MGI:3829418
cx19
Foxp3tm1Kuch/?
Il6tm1Kopf/Il6tm1Kopf
involves: 129S2/SvPas * C57BL/6 MGI:3851995
cx20
ApcMin/Apc+
Il6tm1Kopf/Il6tm1Kopf
involves: 129S2/SvPas * C57BL/6 MGI:4365606
cx21
Il6tm1Kopf/Il6+
Ncoa5tm1Hxia/Ncoa5+
involves: 129S2/SvPas * C57BL/6 MGI:5581715
cx22
Il6tm1Kopf/Il6+
Ncoa5tm1Hxia/Ncoa5tm1Hxia
involves: 129S2/SvPas * C57BL/6 MGI:5581717
cx23
Il6tm1Kopf/Il6tm1Kopf
Il6ratm1.2Drew/Il6ratm1.2Drew
involves: 129S2/SvPas * C57BL/6 * C57BL/6N * FVB/N * SJL MGI:4456869
cx24
Il6tm1Kopf/Il6tm1Kopf
Tg(H2-K-IL6)2Srj/0
involves: 129S2/SvPas * C57BL/6 * DBA/2 MGI:5582604
cx25
Galctwi/Galctwi
Il6tm1Kopf/Il6tm1Kopf
involves: 129S2/SvPas * C57BL/6J * CE/J MGI:4452118


Genotype
MGI:3629043
hm1
Allelic
Composition
Il6tm1Kopf/Il6tm1Kopf
Genetic
Background
B6.129S2-Il6tm1Kopf/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• the percentage of CD19+ B cell progenitors in the bone marrow is decreased from 58% to 35% (J:117320)
• the percentage of CD19+ B cell progenitors in the bone marrow is decreased from 58% to 35% (J:117320)
• after restimulation of spleen cells with keyhole limpet hemocyanin one week following immunization of mutant mice, reduced interferon gamma production is observed (J:123351)
• after restimulation of spleen cells with keyhole limpet hemocyanin one week following immunization of mutant mice, reduced interferon gamma production is observed (J:123351)
• after restimulation of spleen cells with keyhole limpet hemocyanin one week following immunization of mutant mice, enhanced Il-4 secretion is observed (J:123351)
• after restimulation of spleen cells with keyhole limpet hemocyanin one week following immunization of mutant mice, enhanced Il-4 secretion is observed (J:123351)
• intraperitoneal administration of LPS does not induce production of Il6 in the livers of mutants compared to wild-type where expression is increase (J:109359)
• intraperitoneal administration of LPS does not induce production of Il6 in the livers of mutants compared to wild-type where expression is increase (J:109359)
• mice treated with collagen II exhibit a lack of disease incident with normal joints compared with wild-type mice (J:208213)
• mice treated with collagen II exhibit a lack of disease incident with normal joints compared with wild-type mice (J:208213)

homeostasis/metabolism
• injection of Il1beta results in body temperature elevation by about 0.5C (J:136166)
• injection of Il1beta results in body temperature elevation by about 0.5C (J:136166)
• inhibition of hepatic glucose production by ICV infusion of insulin is attenuated (J:109359)
• inhibition of hepatic glucose production assessed by a euglycemic hyperinsulinemic clamp is also attenuated (J:109359)
• inhibition of hepatic glucose production by ICV infusion of insulin is attenuated (J:109359)
• inhibition of hepatic glucose production assessed by a euglycemic hyperinsulinemic clamp is also attenuated (J:109359)
• decreased fasting glucagon levels on a high fat diet (J:139138)
• decreased fasting glucagon levels on a high fat diet (J:139138)
• decreased fasting insulin levels on a high fat diet (J:139138)
• decreased fasting insulin levels on a high fat diet (J:139138)
• impaired glucose tolerance on a high fat diet (J:139138)
• impaired glucose tolerance on a high fat diet (J:139138)

hematopoietic system
• the percentage of CD19+ B cell progenitors in the bone marrow is decreased from 58% to 35% (J:117320)
• the percentage of CD19+ B cell progenitors in the bone marrow is decreased from 58% to 35% (J:117320)

behavior/neurological
• increased latency to "give up" in a forced swim test (J:146951)
• increased latency to "give up" in a forced swim test (J:146951)
• significantly decreased time spent in the open arms of an elevated maze (J:96218)
• significantly decreased number of entries into the open arms of an elevated maze (J:96218)
• significantly decreased time spent in the open arms of an elevated maze (J:96218)
• significantly decreased number of entries into the open arms of an elevated maze (J:96218)
• less time spent in the illuminated areas of a light-dark box (J:146951)
• less time spent in the illuminated areas of a light-dark box (J:146951)
• lower latency to escape adverse stimuli (J:146951)
• fewer failures to escape adverse stimuli (J:146951)
• lower latency to escape adverse stimuli (J:146951)
• fewer failures to escape adverse stimuli (J:146951)
• increased locomotor activity in open field tests (J:96218)
• increased locomotor activity in open field tests (J:96218)
• increased time in non-REM sleep after sleep deprivation persists longer than for controls but increase in time is equivalent (J:105279)
• increased time in non-REM sleep after sleep deprivation persists longer than for controls but increase in time is equivalent (J:105279)
• injection of Il1beta results in reduced dark phase wakefulness (J:136166)
• injection of Il1beta results in increased non REM sleep (J:136166)
• injection of Il1beta results in reduced dark phase wakefulness (J:136166)
• injection of Il1beta results in increased non REM sleep (J:136166)
• 30% increased time in REM sleep over a 24 hour period (J:105279)
• most extra REM sleep occurs in the light cycle (J:105279)
• length of REM bouts is normal but number of bouts increases (J:105279)
• 30% increased time in REM sleep over a 24 hour period (J:105279)
• most extra REM sleep occurs in the light cycle (J:105279)
• length of REM bouts is normal but number of bouts increases (J:105279)

endocrine/exocrine glands
• alpha cell mass fails to increase on a high fat diet as it does in controls (J:139138)
• alpha cell mass fails to increase on a high fat diet as it does in controls (J:139138)
• decreased fasting glucagon levels on a high fat diet (J:139138)
• decreased fasting glucagon levels on a high fat diet (J:139138)
• decreased fasting insulin levels on a high fat diet (J:139138)
• decreased fasting insulin levels on a high fat diet (J:139138)

skeleton
• mice treated with collagen II exhibit a lack of disease incident with normal joints compared with wild-type mice (J:208213)
• mice treated with collagen II exhibit a lack of disease incident with normal joints compared with wild-type mice (J:208213)




Genotype
MGI:3837132
hm2
Allelic
Composition
Il6tm1Kopf/Il6tm1Kopf
Genetic
Background
involves: 129S2/SvPas
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 60% mortality at day 12 after inoculation with C. rodentium (J:161073)
• 60% mortality at day 12 after inoculation with C. rodentium (J:161073)

immune system
• mice challenged with Staphylococcus epidermidis cell-free supernatant exhibit impaired T cells (including CD4+, Th1, and Th17 cells) recruitment and production of IL17a compared with similarly treated wild-type mice (J:159479)
• mice challenged with Staphylococcus epidermidis cell-free supernatant exhibit impaired T cells (including CD4+, Th1, and Th17 cells) recruitment and production of IL17a compared with similarly treated wild-type mice (J:159479)
• mice challenged with Staphylococcus epidermidis cell-free supernatant exhibit fewer IL17a producing cells compared to in similarly treated wild-type mice (J:159479)
• mice challenged with Staphylococcus epidermidis cell-free supernatant exhibit fewer IL17a producing cells compared to in similarly treated wild-type mice (J:159479)
• following carrageenan induced inflammation, mice exhibit impaired neutrophil resolution after 7 days and delayed macrophage infiltration compared to in similarly treated wild-type mice (J:160966)
• following carrageenan induced inflammation, mice exhibit impaired neutrophil resolution after 7 days and delayed macrophage infiltration compared to in similarly treated wild-type mice (J:160966)
• 60% mortality at day 12 after inoculation with C. rodentium (J:161073)
• 60% mortality at day 12 after inoculation with C. rodentium (J:161073)

homeostasis/metabolism
• at healing wounds, mice exhibit delayed re-epithelialization, formation of granulation tissue, macrophage infiltration, fibrin clearance, and vascularization compared with wild-type mice (J:160966)
• at healing wounds, mice exhibit delayed re-epithelialization, formation of granulation tissue, macrophage infiltration, fibrin clearance, and vascularization compared with wild-type mice (J:160966)
• wounds become expanded beyond the boundaries of the original wound unlike in wild-type mice (J:160966)
• wounds become expanded beyond the boundaries of the original wound unlike in wild-type mice (J:160966)
• 24 hours after scalpel cortex injury, mice exhibit reduced microglial and astrocyte reaction compared with similarly treated wild-type mice (J:89814)
• 24 hours after scalpel cortex injury, mice exhibit reduced microglial and astrocyte reaction compared with similarly treated wild-type mice (J:89814)
• following exposure to acid-induced acute lung injury, mice exhibit alleviated symptoms compared to wild-type mice (J:145306)
• following exposure to acid-induced acute lung injury, mice exhibit alleviated symptoms compared to wild-type mice (J:145306)

liver/biliary system
• modestly reduced oval cell response to a choline deficient diet and ethionine in the drinking water (J:66448)
• modestly reduced oval cell response to a choline deficient diet and ethionine in the drinking water (J:66448)

nervous system
• 24 hours after scalpel cortex injury, mice exhibit reduced microglial and astrocyte reaction compared with similarly treated wild-type mice (J:89814)
• 24 hours after scalpel cortex injury, mice exhibit reduced microglial and astrocyte reaction compared with similarly treated wild-type mice (J:89814)

hematopoietic system
• mice challenged with Staphylococcus epidermidis cell-free supernatant exhibit impaired T cells (including CD4+, Th1, and Th17 cells) recruitment and production of IL17a compared with similarly treated wild-type mice (J:159479)
• mice challenged with Staphylococcus epidermidis cell-free supernatant exhibit impaired T cells (including CD4+, Th1, and Th17 cells) recruitment and production of IL17a compared with similarly treated wild-type mice (J:159479)




Genotype
MGI:2180049
hm3
Allelic
Composition
Il6tm1Kopf/Il6tm1Kopf
Genetic
Background
involves: 129S2/SvPas * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• lower body weight at 4 months of age is due largely to lower fat mass (J:105633)
• lower body weight at 4 months of age is due largely to lower fat mass (J:105633)
• obesity develops by 8 months of age (J:105633)
• obesity develops by 8 months of age (J:105633)

immune system
• severe erosion of the intestinal epithelium from exposure to 3.5% dextran sodium sulfate (J:79073)
• severe erosion of the intestinal epithelium from exposure to 3.5% dextran sodium sulfate (J:79073)
• thymocytes are consistently reduced by 20-40% (J:17360)
• thymocytes are consistently reduced by 20-40% (J:17360)
• T cells are reduced in the periphery by 20-40% (J:17360)
• T cells are reduced in the periphery by 20-40% (J:17360)
• modest increase in microglial density after haloperidol treatment relative to the increase seen in controls (J:79142)
• modest increase in microglial density after haloperidol treatment relative to the increase seen in controls (J:79142)
• cytolytic activity of CD8 T cells to vaccinia virus infected cells is reduced 3-10 fold (J:17360)
• cytolytic activity of CD8 T cells to vaccinia virus infected cells is reduced 3-10 fold (J:17360)
• 100-fold reduction in SAA production by the liver in response to turpentine injection or listeria infection (J:17360)
• 100-fold reduction in SAA production by the liver in response to turpentine injection or listeria infection (J:17360)
• 10 to 100 fold increase in bacterial titers in the liver and spleen of mice infected with Listeria (J:17360)
• 10 to 100 fold increase in bacterial titers in the liver and spleen of mice infected with Listeria (J:17360)
• viral titers are 10-1000 fold higher in the ovaries and lungs of vaccinia virus infected mice (J:17360)
• viral titers are 10-1000 fold higher in the ovaries and lungs of vaccinia virus infected mice (J:17360)

hematopoietic system
• thymocytes are consistently reduced by 20-40% (J:17360)
• thymocytes are consistently reduced by 20-40% (J:17360)
• T cells are reduced in the periphery by 20-40% (J:17360)
• T cells are reduced in the periphery by 20-40% (J:17360)
• modest increase in microglial density after haloperidol treatment relative to the increase seen in controls (J:79142)
• modest increase in microglial density after haloperidol treatment relative to the increase seen in controls (J:79142)
• cytolytic activity of CD8 T cells to vaccinia virus infected cells is reduced 3-10 fold (J:17360)
• cytolytic activity of CD8 T cells to vaccinia virus infected cells is reduced 3-10 fold (J:17360)

cardiovascular system
• fewer capillaries in the heart (J:150895)
• fewer capillaries in the heart (J:150895)
• loss of cell-cell interaction between myocytes and fibroblasts (J:150895)
• increased number of fibroblasts and decreased numbers of myocytes (J:150895)
• loss of cell-cell interaction between myocytes and fibroblasts (J:150895)
• increased number of fibroblasts and decreased numbers of myocytes (J:150895)
• heart weight/body weight and heart weight/tibia length ratios both significantly reduced (J:150895)
• heart weight/body weight and heart weight/tibia length ratios both significantly reduced (J:150895)
• modestly increased interstitial collagen (J:150895)
• modestly increased interstitial collagen (J:150895)
• both anterior and posterior walls of the left ventricle are thin (J:150895)
• increased interstitial collagen in the free walls of both left and right ventricles (J:150895)
• both anterior and posterior walls of the left ventricle are thin (J:150895)
• increased interstitial collagen in the free walls of both left and right ventricles (J:150895)
• increased cell proliferation and apoptosis in 5 day old hearts (J:150895)
• proliferation at 5 days primarily by non myocytes (J:150895)
• apoptosis at 5 days primarily of myocytes (J:150895)
• increased cell proliferation and apoptosis in 5 day old hearts (J:150895)
• proliferation at 5 days primarily by non myocytes (J:150895)
• apoptosis at 5 days primarily of myocytes (J:150895)
• both fractional shortening and ejection fraction are decreased in adults and at 5 and 15 days of age (J:150895)
• cardiac dysfunction beginning at 15 days of age (J:150895)
• cardiac dilation is more or less normal at 5 days of age (J:150895)
• both fractional shortening and ejection fraction are decreased in adults and at 5 and 15 days of age (J:150895)
• cardiac dysfunction beginning at 15 days of age (J:150895)
• cardiac dilation is more or less normal at 5 days of age (J:150895)

behavior/neurological
• increased latency to float in a forced swimming test (J:147420)
• reduced despair behavior (J:147420)
• increased latency to float in a forced swimming test (J:147420)
• reduced despair behavior (J:147420)
• more time in the closed arms of an elevated + maze after forced swimming tests (J:147420)
• more time in the closed arms of an elevated + maze after forced swimming tests (J:147420)
• reduced exploration in initial phase of novel object recognition tests (J:147420)
• reduced exploration in initial phase of novel object recognition tests (J:147420)
• increased exploration in novel object recognition tests (J:148881)
• increased exploration in novel object recognition tests (J:148881)
• reduced object recognition when retested (J:147420)
• reduced object recognition when retested (J:147420)
• greater object recognition memory (J:148881)
• greater object recognition memory (J:148881)
• longer escape latencies in a Morris water maze (J:147420)
• shorter time spent in the target quadrant of a Morris water maze (J:147420)
• slower to relocate platform after it is moved (J:147420)
• longer escape latencies in a Morris water maze (J:147420)
• shorter time spent in the target quadrant of a Morris water maze (J:147420)
• slower to relocate platform after it is moved (J:147420)

nervous system
• parvalbumin positive interneurons in the hippocampus suffer less loss in numbers with age (J:148881)
• parvalbumin positive interneurons in the hippocampus suffer less loss in numbers with age (J:148881)
• modest increase in microglial density after haloperidol treatment relative to the increase seen in controls (J:79142)
• modest increase in microglial density after haloperidol treatment relative to the increase seen in controls (J:79142)
• density fails to increase in response to neurotoxin (6-OHDA) lesioning (J:79142)
• density fails to increase in response to neurotoxin (6-OHDA) lesioning (J:79142)
• axon terminal tree is 25% larger in the substantia nigra pars compacta than for controls (J:79142)
• resistant to the effects of haloperidol treatment on terminal trees (J:79142)
• neurotoxin lesion results in reduced terminal tree density (J:79142)
• axon terminal tree is 25% larger in the substantia nigra pars compacta than for controls (J:79142)
• resistant to the effects of haloperidol treatment on terminal trees (J:79142)
• neurotoxin lesion results in reduced terminal tree density (J:79142)
• age induced increase in oxygen consumption in synaptosomes is attenuated (J:148881)
• age induced increase in oxygen consumption in synaptosomes is attenuated (J:148881)

muscle
• both fractional shortening and ejection fraction are decreased in adults and at 5 and 15 days of age (J:150895)
• cardiac dysfunction beginning at 15 days of age (J:150895)
• cardiac dilation is more or less normal at 5 days of age (J:150895)
• both fractional shortening and ejection fraction are decreased in adults and at 5 and 15 days of age (J:150895)
• cardiac dysfunction beginning at 15 days of age (J:150895)
• cardiac dilation is more or less normal at 5 days of age (J:150895)
• migration of primary myoblasts is reduced relative to controls (J:131016)
• migration of primary myoblasts is reduced relative to controls (J:131016)
• proliferation is defective (J:131016)
• proliferation is defective (J:131016)
• cross-sectional area of myofibers does not increase after overload of the plantaris muscle by incapacitation of the gastrocnemius, measured 14 and 42 days after overload (J:131016)
• no change in myonuclear numbers (J:131016)
• cross-sectional area of myofibers does not increase after overload of the plantaris muscle by incapacitation of the gastrocnemius, measured 14 and 42 days after overload (J:131016)
• no change in myonuclear numbers (J:131016)

vision/eye
• higher level of apoptosis after retinal separation from the retinal pigment epithelium (J:136895)
• higher rate of photoreceptor cell death after 1 month (J:136895)
• higher level of apoptosis after retinal separation from the retinal pigment epithelium (J:136895)
• higher rate of photoreceptor cell death after 1 month (J:136895)

skeleton
• callus formed after bone fracture is denser after 2 weeks than is true in controls (J:141482)
• tissue mineral density is less at 4 and 6 weeks after injury than for controls (J:141482)
• greater collagen content at 2 weeks after fracture but not at 4 or 6 weeks (J:141482)
• callus formed after bone fracture is denser after 2 weeks than is true in controls (J:141482)
• tissue mineral density is less at 4 and 6 weeks after injury than for controls (J:141482)
• greater collagen content at 2 weeks after fracture but not at 4 or 6 weeks (J:141482)
• mineral density of cortical bone reduced (J:141482)
• reduced crystallinity relative to controls (J:141482)
• reduced mineral/matrix ratio in cortical bone at both 2 and 4 weeks (J:141482)
• mineral density of cortical bone reduced (J:141482)
• reduced crystallinity relative to controls (J:141482)
• reduced mineral/matrix ratio in cortical bone at both 2 and 4 weeks (J:141482)

tumorigenesis
• reduced incidence of hepatocellular cancer in males treated with diethyl nitrosamine relative to incidence in control males (J:122816)
• reduced incidence of hepatocellular cancer in males treated with diethyl nitrosamine relative to incidence in control males (J:122816)

liver/biliary system
• less necrosis resulting from diethyl nitrosamine treatment (J:122816)
• less necrosis resulting from diethyl nitrosamine treatment (J:122816)
• less hepatic injury in males from treatment with diethyl nitrosamine (J:122816)
• less apoptosis due to diethyl nitrosamine treatment (J:122816)
• less compensatory proliferation as a result of diethyl nitrosamine treatment (J:122816)
• less hepatic injury in males from treatment with diethyl nitrosamine (J:122816)
• less apoptosis due to diethyl nitrosamine treatment (J:122816)
• less compensatory proliferation as a result of diethyl nitrosamine treatment (J:122816)

respiratory system
• elevated respiratory exchange rate in young mice (J:105633)
• elevated respiratory exchange rate in young mice (J:105633)

homeostasis/metabolism
• elevated basal glucose levels at 8 months but not in younger mice (J:105633)
• glucose levels do not differ from controls in young mice after 1 hour of exercise (J:105633)
• elevated basal glucose levels at 8 months but not in younger mice (J:105633)
• glucose levels do not differ from controls in young mice after 1 hour of exercise (J:105633)
• oxygen consumption is not maintained at as high a level after 12 minutes of running as in controls (J:105633)
• oxygen consumption is not maintained at as high a level after 12 minutes of running as in controls (J:105633)
• 100-fold reduction in SAA production by the liver in response to turpentine injection or listeria infection (J:17360)
• 100-fold reduction in SAA production by the liver in response to turpentine injection or listeria infection (J:17360)
• reduced treadmill endurance (J:105633)
• reduced treadmill endurance (J:105633)
• reduced incidence of hepatocellular cancer in males treated with diethyl nitrosamine relative to incidence in control males (J:122816)
• reduced incidence of hepatocellular cancer in males treated with diethyl nitrosamine relative to incidence in control males (J:122816)
• callus formed after bone fracture is denser after 2 weeks than is true in controls (J:141482)
• tissue mineral density is less at 4 and 6 weeks after injury than for controls (J:141482)
• greater collagen content at 2 weeks after fracture but not at 4 or 6 weeks (J:141482)
• callus formed after bone fracture is denser after 2 weeks than is true in controls (J:141482)
• tissue mineral density is less at 4 and 6 weeks after injury than for controls (J:141482)
• greater collagen content at 2 weeks after fracture but not at 4 or 6 weeks (J:141482)

endocrine/exocrine glands
• develops more slowly (J:125449)
• develops more slowly (J:125449)

digestive/alimentary system
• severe erosion of the intestinal epithelium from exposure to 3.5% dextran sodium sulfate (J:79073)
• severe erosion of the intestinal epithelium from exposure to 3.5% dextran sodium sulfate (J:79073)

integument
• develops more slowly (J:125449)
• develops more slowly (J:125449)

cellular
• migration of primary myoblasts is reduced relative to controls (J:131016)
• migration of primary myoblasts is reduced relative to controls (J:131016)
• proliferation is defective (J:131016)
• proliferation is defective (J:131016)




Genotype
MGI:4453191
hm4
Allelic
Composition
Il6tm1Kopf/Il6tm1Kopf
Genetic
Background
involves: 129S2/SvPas * C57BL/6J * CE/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• a substantial proportion of homozygotes develop generalized seizures after 250 days of age (J:63197)
• a substantial proportion of homozygotes develop generalized seizures after 250 days of age (J:63197)

nervous system
• a substantial proportion of homozygotes develop generalized seizures after 250 days of age (J:63197)
• a substantial proportion of homozygotes develop generalized seizures after 250 days of age (J:63197)




Genotype
MGI:4417905
cn5
Allelic
Composition
Il6tm1Kopf/Il6tm1Kopf
Junbtm3Wag/Junbtm3Wag
Tg(KRT5-cre)1Tak/0
Genetic
Background
involves: 129/Sv * 129P2/OlaHsd * 129S2/SvPas * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
Junbtm3Wag mutation (0 available); any Junb mutation (0 available)
Tg(KRT5-cre)1Tak mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
N
• mice exhibit normal lifespan unlike Junbtm3Wag/Junbtm3Wag Tg(KRT5-cre)1Tak mice (J:155575)
• mice exhibit normal lifespan unlike Junbtm3Wag/Junbtm3Wag Tg(KRT5-cre)1Tak mice (J:155575)

immune system
N
• mice exhibit a rescue of the systemic lupus erythematosus associated phenotypes observed in Junbtm3Wag/Junbtm3Wag Tg(KRT5-cre)1Tak mice including normal lymph node architecture, plasma cell count, and antinuclear autoantibodies (J:155575)
• mice exhibit a rescue of the systemic lupus erythematosus associated phenotypes observed in Junbtm3Wag/Junbtm3Wag Tg(KRT5-cre)1Tak mice including normal lymph node architecture, plasma cell count, and antinuclear autoantibodies (J:155575)
• mild (J:155575)
• mild (J:155575)

renal/urinary system
N
• mice exhibit a rescue of the lupus associated kidney phenotypes observed in Junbtm3Wag/Junbtm3Wag Tg(KRT5-cre)1Tak mice (J:155575)
• mice exhibit a rescue of the lupus associated kidney phenotypes observed in Junbtm3Wag/Junbtm3Wag Tg(KRT5-cre)1Tak mice (J:155575)

homeostasis/metabolism
N
• ce exhibit normal urine albumin levels unlike in Junbtm3Wag/Junbtm3Wag Tg(KRT5-cre)1Tak mice (J:155575)
• ce exhibit normal urine albumin levels unlike in Junbtm3Wag/Junbtm3Wag Tg(KRT5-cre)1Tak mice (J:155575)

integument
N
• mice exhibit a rescue of the lupus associated skin phenotypes observed in Junbtm3Wag/Junbtm3Wag Tg(KRT5-cre)1Tak mice (J:155575)
• mice exhibit a rescue of the lupus associated skin phenotypes observed in Junbtm3Wag/Junbtm3Wag Tg(KRT5-cre)1Tak mice (J:155575)
• mild (J:155575)
• mild (J:155575)
• mild (J:155575)
• mild (J:155575)
• milder than in Junbtm3Wag/Junbtm3Wag Tg(KRT5-cre)1Tak mice (J:155575)
• milder than in Junbtm3Wag/Junbtm3Wag Tg(KRT5-cre)1Tak mice (J:155575)




Genotype
MGI:5515639
cn6
Allelic
Composition
Il6tm1Kopf/Il6+
Prdm1tm1Clme/Prdm1tm1Clme
Tg(Itgax-cre)1-1Reiz/0
Genetic
Background
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
Prdm1tm1Clme mutation (1 available); any Prdm1 mutation (9 available)
Tg(Itgax-cre)1-1Reiz mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• mice do not develop autoantibodies, they mount an antibody response indistinguishable from control mice to NP-CGG, dendritic cells express the same level of IL-6 as dendritic cells from control mice after LPS stimulation, and show normal levels of follicular T helper cells and germinal cells in the spleen (J:178876)
• mice do not develop autoantibodies, they mount an antibody response indistinguishable from control mice to NP-CGG, dendritic cells express the same level of IL-6 as dendritic cells from control mice after LPS stimulation, and show normal levels of follicular T helper cells and germinal cells in the spleen (J:178876)




Genotype
MGI:5563040
cx7
Allelic
Composition
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu
Il6tm1Kopf/Il6tm1Kopf
Genetic
Background
B6.Cg-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu Il6tm1Kopf
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu mutation (0 available); any Ash1l mutation (3 available)
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• reduced inflammation compared with Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu homozygotes (J:208213)
• reduced inflammation compared with Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu homozygotes (J:208213)
• compared with Il6tm1Kopf homozygotes (J:208213)
• compared with Il6tm1Kopf homozygotes (J:208213)

skeleton
• compared with Il6tm1Kopf homozygotes (J:208213)
• compared with Il6tm1Kopf homozygotes (J:208213)




Genotype
MGI:5308014
cx8
Allelic
Composition
Il6tm1Kopf/Il6tm1Kopf
Tg(ED-L2-IL1RN/IL1B)#Tcw/?
Genetic
Background
B6.Cg-Il6tm1Kopf Tg(ED-L2-IL1RN/IL1B)#Tcw
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
Tg(ED-L2-IL1RN/IL1B)#Tcw mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
digestive/alimentary system
N
• absence of Il6 expression completely abolishes the metaplastic and dysplastic phenotypes seen in transgenic mice expressing Il6 (J:180282)
• absence of Il6 expression completely abolishes the metaplastic and dysplastic phenotypes seen in transgenic mice expressing Il6 (J:180282)
• minor inflammatory response (J:180282)
• minor inflammatory response (J:180282)

immune system
• minor inflammatory response (J:180282)
• minor inflammatory response (J:180282)

Mouse Models of Human Disease
OMIM ID Ref(s)
NOT Barrett Esophagus 614266 J:180282




Genotype
MGI:5308015
cx9
Allelic
Composition
Il6tm1Kopf/Il6+
Tg(ED-L2-IL1RN/IL1B)#Tcw/?
Genetic
Background
B6.Cg-Il6tm1Kopf Tg(ED-L2-IL1RN/IL1B)#Tcw
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
Tg(ED-L2-IL1RN/IL1B)#Tcw mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
digestive/alimentary system
N
• reduced of Il6 expression completely decreases metaplasia and abolishes dysplasia (J:180282)
• reduced of Il6 expression completely decreases metaplasia and abolishes dysplasia (J:180282)

immune system




Genotype
MGI:3838993
cx10
Allelic
Composition
Il6tm1Kopf/Il6tm1Kopf
Inpp5dtm1Rkh/Inpp5dtm1Rkh
Genetic
Background
involves: 129 * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
Inpp5dtm1Rkh mutation (1 available); any Inpp5d mutation (39 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• the percentage of prolymphocyte in the bone marrow is slightly less than wild-type (35% versus 27%) (J:117320)
• the percentage of prolymphocyte in the bone marrow is slightly less than wild-type (35% versus 27%) (J:117320)
• the percentage of CD19+ B cell progenitors in the bone marrow is decreased by almost 4-fold (J:117320)
• the percentage of CD19+ B cell progenitors in the bone marrow is decreased by almost 4-fold (J:117320)
• 78% of mutant bone marrow cells are Mac-1+ compared to 56% in wild-type (J:117320)
• 78% of mutant bone marrow cells are Mac-1+ compared to 56% in wild-type (J:117320)

hematopoietic system
• the percentage of prolymphocyte in the bone marrow is slightly less than wild-type (35% versus 27%) (J:117320)
• the percentage of prolymphocyte in the bone marrow is slightly less than wild-type (35% versus 27%) (J:117320)
• the percentage of CD19+ B cell progenitors in the bone marrow is decreased by almost 4-fold (J:117320)
• the percentage of CD19+ B cell progenitors in the bone marrow is decreased by almost 4-fold (J:117320)
• 78% of mutant bone marrow cells are Mac-1+ compared to 56% in wild-type (J:117320)
• 78% of mutant bone marrow cells are Mac-1+ compared to 56% in wild-type (J:117320)
• there is a 2-fold decrease in Lin-c-KitloSca-1lo population in the bone marrow that contains the hematopoietic stem cell population (J:117320)
• there is a 2-fold decrease in Lin-c-KitloSca-1lo population in the bone marrow that contains the hematopoietic stem cell population (J:117320)




Genotype
MGI:4355832
cx11
Allelic
Composition
Il6tm1Kopf/Il6tm1Kopf
Tanktm1Aki/Tanktm1Aki
Genetic
Background
involves: 129/Sv * 129S2/SvPas * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
Tanktm1Aki mutation (0 available); any Tank mutation (4 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• the glomerulonephritis and the auto-antibodies that occur in Tank-null mice do not occur on a IL-6 deficient background (J:151757)
• the glomerulonephritis and the auto-antibodies that occur in Tank-null mice do not occur on a IL-6 deficient background (J:151757)




Genotype
MGI:3604406
cx12
Allelic
Composition
Il11ra1tm1Wehi/Il11ra1tm1Wehi
Il6tm1Kopf/Il6tm1Kopf
Genetic
Background
involves: 129/Sv * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il11ra1tm1Wehi mutation (1 available); any Il11ra1 mutation (3 available)
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
digestive/alimentary system
• adult double homozygotes do NOT develop spontaneous gastric hyperplasia or gastric adenomas (J:79073)
• however, double homozygotes exhibit enhanced colitis in response to DSS-mediated intestinal injury, as shown by increased inflammation, crypt damage, severe weight loss, and increased morbidity relative to wild-type or Il11ra1tm1Wehi mice (J:79073)
• adult double homozygotes do NOT develop spontaneous gastric hyperplasia or gastric adenomas (J:79073)
• however, double homozygotes exhibit enhanced colitis in response to DSS-mediated intestinal injury, as shown by increased inflammation, crypt damage, severe weight loss, and increased morbidity relative to wild-type or Il11ra1tm1Wehi mice (J:79073)

immune system
• adult double homozygotes do NOT develop spontaneous gastric hyperplasia or gastric adenomas (J:79073)
• however, double homozygotes exhibit enhanced colitis in response to DSS-mediated intestinal injury, as shown by increased inflammation, crypt damage, severe weight loss, and increased morbidity relative to wild-type or Il11ra1tm1Wehi mice (J:79073)
• adult double homozygotes do NOT develop spontaneous gastric hyperplasia or gastric adenomas (J:79073)
• however, double homozygotes exhibit enhanced colitis in response to DSS-mediated intestinal injury, as shown by increased inflammation, crypt damage, severe weight loss, and increased morbidity relative to wild-type or Il11ra1tm1Wehi mice (J:79073)




Genotype
MGI:3837308
cx13
Allelic
Composition
Il6tm1Kopf/Il6tm1Kopf
Il6sttm1Ern/Il6sttm1Ern
Genetic
Background
involves: 129S1/Sv * 129S2/SvPas
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6sttm1Ern mutation (0 available); any Il6st mutation (18 available)
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• neutrophil infiltration of the peritoneal cavity and subsequent clearance in induced inflammation normal (J:139226)
• neutrophil infiltration of the peritoneal cavity and subsequent clearance in induced inflammation normal (J:139226)
• mice are resistant to LPS-induced shock (J:168781)
• mice are resistant to LPS-induced shock (J:168781)




Genotype
MGI:4834760
cx14
Allelic
Composition
Il6tm1Kopf/Il6tm1Kopf
Liftm1Stw/Liftm1Stw
Genetic
Background
involves: 129S1/Sv * 129S2/SvPas * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
Liftm1Stw mutation (1 available); any Lif mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• 24 hours after scalpel cortex injury, mice exhibit reduced microglial and astrocyte reaction compared with similarly treated wild-type mice but similar to in single homozygotes (J:89814)
• 24 hours after scalpel cortex injury, mice exhibit reduced microglial and astrocyte reaction compared with similarly treated wild-type mice but similar to in single homozygotes (J:89814)

nervous system
• 24 hours after scalpel cortex injury, mice exhibit reduced microglial and astrocyte reaction compared with similarly treated wild-type mice but similar to in single homozygotes (J:89814)
• 24 hours after scalpel cortex injury, mice exhibit reduced microglial and astrocyte reaction compared with similarly treated wild-type mice but similar to in single homozygotes (J:89814)




Genotype
MGI:3696456
cx15
Allelic
Composition
Ctsctm1Ley/Ctsctm1Ley
Il6tm1Kopf/Il6tm1Kopf
Genetic
Background
involves: 129S2/SvPas * 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctsctm1Ley mutation (0 available); any Ctsc mutation (2 available)
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• survival of experimentally induced sepsis is similar to that of controls (J:88160)
• survival of experimentally induced sepsis is similar to that of controls (J:88160)




Genotype
MGI:3706955
cx16
Allelic
Composition
Il6tm1Kopf/Il6tm1Kopf
Npc1m1N/Npc1m1N
Genetic
Background
involves: 129S2/SvPas * BALB/c * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
Npc1m1N mutation (2 available); any Npc1 mutation (17 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• nmber of activated microglial and astroglial cells is decreased in 6-week old mice compared to Il6-sufficient, Npc1-null mice (J:118352)
• nmber of activated microglial and astroglial cells is decreased in 6-week old mice compared to Il6-sufficient, Npc1-null mice (J:118352)




Genotype
MGI:5581716
cx17
Allelic
Composition
Il6tm1Kopf/Il6+
Ncoa5tm1Hxia/Ncoa5+
Genetic
Background
involves: 129S2/SvPas * BALB/c * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
Ncoa5tm1Hxia mutation (0 available); any Ncoa5 mutation (35 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
N
• unlike Ncoa5tm1Hxia male heterozygotes, male mice exhibit normal circulating glucose levels and improved glucose tolerance (J:207622)
• unlike Ncoa5tm1Hxia male heterozygotes, male mice exhibit normal circulating glucose levels and improved glucose tolerance (J:207622)




Genotype
MGI:3829418
cx18
Allelic
Composition
Il6tm1Kopf/Il6tm1Kopf
Tg(Rorc-EGFP)1Ebe/?
Genetic
Background
involves: 129S2/SvPas * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
Tg(Rorc-EGFP)1Ebe mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• splenic Th-17 cells that have alphabeta TCR and are GFP-positive are decreased by half compared to controls (J:137020)
• the ratio of IL-17 producing cells to IL-10 producing cells among the GFP-positive T cell population is significantly decreased (J:137020)
• numbers of Th17 gammadelta T cells are normal (J:137020)
• splenic Th-17 cells that have alphabeta TCR and are GFP-positive are decreased by half compared to controls (J:137020)
• the ratio of IL-17 producing cells to IL-10 producing cells among the GFP-positive T cell population is significantly decreased (J:137020)
• numbers of Th17 gammadelta T cells are normal (J:137020)

immune system
• splenic Th-17 cells that have alphabeta TCR and are GFP-positive are decreased by half compared to controls (J:137020)
• the ratio of IL-17 producing cells to IL-10 producing cells among the GFP-positive T cell population is significantly decreased (J:137020)
• numbers of Th17 gammadelta T cells are normal (J:137020)
• splenic Th-17 cells that have alphabeta TCR and are GFP-positive are decreased by half compared to controls (J:137020)
• the ratio of IL-17 producing cells to IL-10 producing cells among the GFP-positive T cell population is significantly decreased (J:137020)
• numbers of Th17 gammadelta T cells are normal (J:137020)




Genotype
MGI:3851995
cx19
Allelic
Composition
Foxp3tm1Kuch/?
Il6tm1Kopf/Il6tm1Kopf
Genetic
Background
involves: 129S2/SvPas * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxp3tm1Kuch mutation (0 available); any Foxp3 mutation (30 available)
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• immunization with MOG-peptide leads to less differentiation of Th17 effector cells (J:123352)
• when Treg cells are depleted, Th17 T cells form upon MOG immunization (J:123352)
• na´ve T cells can be differentiated in vitro to Th17 T cells by incubating with Tgf-beta plus IL-21 albeit to a lesser degree than controls (J:123352)
• immunization with MOG-peptide leads to less differentiation of Th17 effector cells (J:123352)
• when Treg cells are depleted, Th17 T cells form upon MOG immunization (J:123352)
• na´ve T cells can be differentiated in vitro to Th17 T cells by incubating with Tgf-beta plus IL-21 albeit to a lesser degree than controls (J:123352)
• numbers of FoxP3+ T cells are increased in MOG-immunized mice compared to immunized controls (J:123352)
• the ratio of MOG-specific Treg to effector T cells is reversed compared to controls (J:123352)
• numbers of FoxP3+ T cells are increased in MOG-immunized mice compared to immunized controls (J:123352)
• the ratio of MOG-specific Treg to effector T cells is reversed compared to controls (J:123352)

homeostasis/metabolism
• mice were confirmed not to produce IL-6 (J:123352)
• mice were confirmed not to produce IL-6 (J:123352)

immune system
• immunization with MOG-peptide leads to less differentiation of Th17 effector cells (J:123352)
• when Treg cells are depleted, Th17 T cells form upon MOG immunization (J:123352)
• na´ve T cells can be differentiated in vitro to Th17 T cells by incubating with Tgf-beta plus IL-21 albeit to a lesser degree than controls (J:123352)
• immunization with MOG-peptide leads to less differentiation of Th17 effector cells (J:123352)
• when Treg cells are depleted, Th17 T cells form upon MOG immunization (J:123352)
• na´ve T cells can be differentiated in vitro to Th17 T cells by incubating with Tgf-beta plus IL-21 albeit to a lesser degree than controls (J:123352)
• numbers of FoxP3+ T cells are increased in MOG-immunized mice compared to immunized controls (J:123352)
• the ratio of MOG-specific Treg to effector T cells is reversed compared to controls (J:123352)
• numbers of FoxP3+ T cells are increased in MOG-immunized mice compared to immunized controls (J:123352)
• the ratio of MOG-specific Treg to effector T cells is reversed compared to controls (J:123352)
• mice were confirmed not to produce IL-6 (J:123352)
• mice were confirmed not to produce IL-6 (J:123352)
• less IL-17 is secreted when T cells from MOG-challenged mice are presented MOG peptide in vitro (J:123352)
• less IL-17 is secreted when T cells from MOG-challenged mice are presented MOG peptide in vitro (J:123352)
• mice are resistant to EAE induced by immunization with MOG-peptide (J:123352)
• mice are resistant to EAE induced by immunization with MOG-peptide (J:123352)




Genotype
MGI:4365606
cx20
Allelic
Composition
ApcMin/Apc+
Il6tm1Kopf/Il6tm1Kopf
Genetic
Background
involves: 129S2/SvPas * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
ApcMin mutation (8 available); any Apc mutation (53 available)
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
muscle
N
• no gastrocnemius muscle wasting (J:130429)
• no gastrocnemius muscle wasting (J:130429)

adipose tissue
N
• normal epididymal fat pads (J:130429)
• normal epididymal fat pads (J:130429)

tumorigenesis
• numbers of gastrointestinal polyps 32% lower at 26 weeks than when both Il6 alleles are wild-type (J:130429)
• polyp sizes are reduced (J:130429)
• numbers of gastrointestinal polyps 32% lower at 26 weeks than when both Il6 alleles are wild-type (J:130429)
• polyp sizes are reduced (J:130429)




Genotype
MGI:5581715
cx21
Allelic
Composition
Il6tm1Kopf/Il6+
Ncoa5tm1Hxia/Ncoa5+
Genetic
Background
involves: 129S2/SvPas * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
Ncoa5tm1Hxia mutation (0 available); any Ncoa5 mutation (35 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
N
• Ncoa5tm1Hxia male heterozygotes, male mice are fertile (J:207622)
• Ncoa5tm1Hxia male heterozygotes, male mice are fertile (J:207622)

tumorigenesis
• fewer and smaller maximum tumor volume than in Ncoa5tm1Hxia male heterozygotes (J:207622)
• fewer and smaller maximum tumor volume than in Ncoa5tm1Hxia male heterozygotes (J:207622)

homeostasis/metabolism
N
• unlike Ncoa5tm1Hxia male heterozygotes, male mice exhibit normal circulating glucose levels, glucose tolerance and insulin sensitivity (J:207622)
• unlike Ncoa5tm1Hxia male heterozygotes, male mice exhibit normal circulating glucose levels, glucose tolerance and insulin sensitivity (J:207622)




Genotype
MGI:5581717
cx22
Allelic
Composition
Il6tm1Kopf/Il6+
Ncoa5tm1Hxia/Ncoa5tm1Hxia
Genetic
Background
involves: 129S2/SvPas * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
Ncoa5tm1Hxia mutation (0 available); any Ncoa5 mutation (35 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• no mice are produced from fertile double heterozygotes (J:207622)
• no mice are produced from fertile double heterozygotes (J:207622)




Genotype
MGI:4456869
cx23
Allelic
Composition
Il6tm1Kopf/Il6tm1Kopf
Il6ratm1.2Drew/Il6ratm1.2Drew
Genetic
Background
involves: 129S2/SvPas * C57BL/6 * C57BL/6N * FVB/N * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6ratm1.2Drew mutation (0 available); any Il6ra mutation (8 available)
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• mice exhibit delayed re-epithelialization of small and large wounds is delayed compared to in wild-type mice (J:160966)
• mice exhibit deficits in the formation of granulation tissue at wounds compared with wild-type mice (J:160966)
• however, macroscopic wound closure rates are normal (J:160966)
• mice exhibit delayed re-epithelialization of small and large wounds is delayed compared to in wild-type mice (J:160966)
• mice exhibit deficits in the formation of granulation tissue at wounds compared with wild-type mice (J:160966)
• however, macroscopic wound closure rates are normal (J:160966)




Genotype
MGI:5582604
cx24
Allelic
Composition
Il6tm1Kopf/Il6tm1Kopf
Tg(H2-K-IL6)2Srj/0
Genetic
Background
involves: 129S2/SvPas * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
Tg(H2-K-IL6)2Srj mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
N
• mice exhibit normal spleen and lymph node size, normal IgG levels and do not show hyperplastic germinal centers, extramedullary hematopoiesis, or plasmacytosis in lymphoid tissues at 4-5 months of age (J:185153)
• mice exhibit normal spleen and lymph node size, normal IgG levels and do not show hyperplastic germinal centers, extramedullary hematopoiesis, or plasmacytosis in lymphoid tissues at 4-5 months of age (J:185153)




Genotype
MGI:4452118
cx25
Allelic
Composition
Galctwi/Galctwi
Il6tm1Kopf/Il6tm1Kopf
Genetic
Background
involves: 129S2/SvPas * C57BL/6J * CE/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Galctwi mutation (1 available); any Galc mutation (5 available)
Il6tm1Kopf mutation (7 available); any Il6 mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• the average onset of twitching is earlier in double homozygotes than mice homozygous only for twitcher (22.2 days of age versus 25.9 days of age respectively), although lifespan, body weight and frequency of twitching do not differ significantly (J:56656)
• the average onset of twitching is earlier in double homozygotes than mice homozygous only for twitcher (22.2 days of age versus 25.9 days of age respectively), although lifespan, body weight and frequency of twitching do not differ significantly (J:56656)

nervous system
• leakage of the blood-brain barrier is detected in the cerebrum, hindbrain, and cervical spinal cord as detected by horseradish peroxidase tail vein injection, and immunoglobulin and albumin immunohistochemistry (J:56656)
• lipopolysaccharide injection greatly enhances the blood-brain barrier disruption leading to death (J:56656)
• leakage of the blood-brain barrier is detected in the cerebrum, hindbrain, and cervical spinal cord as detected by horseradish peroxidase tail vein injection, and immunoglobulin and albumin immunohistochemistry (J:56656)
• lipopolysaccharide injection greatly enhances the blood-brain barrier disruption leading to death (J:56656)
• the deep cerebellar white matter shows a significant increase in periodic acid-Schiff staining cells and a trend toward increased lectin-positive cells relative to mice homozygous only for twitcher (J:56656)
• the deep cerebellar white matter shows a significant increase in periodic acid-Schiff staining cells and a trend toward increased lectin-positive cells relative to mice homozygous only for twitcher (J:56656)
• more exaggerated gliosis is found around some vessels and pial surfaces in the double mutants than in mice homozygous only for twitcher (J:56656)
• more exaggerated gliosis is found around some vessels and pial surfaces in the double mutants than in mice homozygous only for twitcher (J:56656)

cardiovascular system
• leakage of the blood-brain barrier is detected in the cerebrum, hindbrain, and cervical spinal cord as detected by horseradish peroxidase tail vein injection, and immunoglobulin and albumin immunohistochemistry (J:56656)
• lipopolysaccharide injection greatly enhances the blood-brain barrier disruption leading to death (J:56656)
• leakage of the blood-brain barrier is detected in the cerebrum, hindbrain, and cervical spinal cord as detected by horseradish peroxidase tail vein injection, and immunoglobulin and albumin immunohistochemistry (J:56656)
• lipopolysaccharide injection greatly enhances the blood-brain barrier disruption leading to death (J:56656)

homeostasis/metabolism
• hindbrain has TNF levels elevated above that found in mice homozygous only for twitcher and mice homozygous only for twitcher have significantly elevated TNF levels in hindbrain (J:56656)
• hindbrain has TNF levels elevated above that found in mice homozygous only for twitcher and mice homozygous only for twitcher have significantly elevated TNF levels in hindbrain (J:56656)

immune system
• hindbrain has TNF levels elevated above that found in mice homozygous only for twitcher and mice homozygous only for twitcher have significantly elevated TNF levels in hindbrain (J:56656)
• hindbrain has TNF levels elevated above that found in mice homozygous only for twitcher and mice homozygous only for twitcher have significantly elevated TNF levels in hindbrain (J:56656)





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
02/02/2016
MGI 6.02
The Jackson Laboratory